William L. Macias, Chief Medical Officer at Immunovant, Inc. (IMVT), sold 5,406 shares at $29.64 ($160K) on 2024-07-17, disclosed to the SEC on 2024-07-19.
Open-market sale of $160k IMVT by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $29.64 | 504 | $15K | 9.3% |
| 2 | $29.64 | 2,362 | $70K | 43.6% |
| 3 | $29.64 | 2,362 | $70K | 43.6% |
| 4 | $30.55 | 31 | $947 | 0.6% |
| 5 | $30.55 | 147 | $4K | 2.8% |
| Total | $29.67 avg | 5,406 |
| $160K |
| 100% |
| Filing → |
| IMVT | SELL | 2024-11-22 | $171K | — | Filing → |
| IMVT | SELL | 2024-10-18 | $167K | — | Filing → |
| IMVT | SELL | 2024-08-23 | $189K | — | Filing → |